Pharma Invest Devos: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharma Invest Devos
Largest movements
- Receivables within one year +€93,993
up €93,993 (+603.0%), from €15,588 to €109,581
of which Trade receivables: +€47,372
- Cash -€15,194
down €15,194 (-58.1%), from €26,152 to €10,957
mainly Receivables within one year (-€93,993)
- Reserves +€61,887
up €61,887 (+11.4%), from €543,945 to €605,831
of which Distributable reserves: +€61,887
- Gross operating margin +€38,867
up €38,867 (+62.9%), from €61,775 to €100,642
- Taxes +€10,051
up €10,051 (+75.4%), from €13,328 to €23,379
- Financial charges +€4,242
up €4,242 (+44.6%), from €9,503 to €13,745
- Staff costs -€1,685
down €1,685 (-52.3%), from €3,219 to €1,534
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €742,900 | €821,619 | +€78,719 | +10.6% |
| Fixed assets | 21/28 | €700,000 | €700,000 | = | 0.0% |
| Financial fixed assets | 28 | €700,000 | €700,000 | = | 0.0% |
| Current assets | 29/58 | €42,900 | €121,619 | +€78,719 | +183.5% |
| Amounts receivable within one year | 40/41 | €15,588 | €109,581 | +€93,993 | +603.0% |
| Trade receivables | 40 | - | €47,372 | +€47,372 | |
| Other amounts receivable | 41 | €15,588 | €62,209 | +€46,621 | +299.1% |
| Cash at bank and in hand | 54/58 | €26,152 | €10,957 | -€15,194 | -58.1% |
| Deferred charges and accrued income | 490/1 | €1,160 | €1,081 | -€79 | -6.8% |
| Total equity and liabilities | 10/49 | €742,900 | €821,619 | +€78,719 | +10.6% |
| Equity | 10/15 | €556,345 | €618,231 | +€61,887 | +11.1% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Outside capital | 11 | €12,400 | €12,400 | = | 0.0% |
| Other | 1109/19 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €543,945 | €605,831 | +€61,887 | +11.4% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €542,085 | €603,971 | +€61,887 | +11.4% |
| Amounts payable | 17/49 | €186,555 | €203,388 | +€16,833 | +9.0% |
| Amounts payable within one year | 42/48 | €175,080 | €187,454 | +€12,373 | +7.1% |
| Trade debts | 44 | €587 | €1,758 | +€1,171 | +199.4% |
| Suppliers | 440/4 | €587 | €1,758 | +€1,171 | +199.4% |
| Taxes, remuneration and social security | 45 | €8,705 | €11,736 | +€3,031 | +34.8% |
| Taxes | 450/3 | €8,319 | €11,640 | +€3,321 | +39.9% |
| Remuneration and social security | 454/9 | €386 | €96 | -€290 | -75.2% |
| Other amounts payable | 47/48 | €165,788 | €173,961 | +€8,172 | +4.9% |
| Accrued charges and deferred income | 492/3 | €11,475 | €15,934 | +€4,459 | +38.9% |
| Remuneration, social security and pensions | 62 | €3,219 | €1,534 | -€1,685 | -52.3% |
| Other operating charges | 640/8 | €738 | €689 | -€49 | -6.7% |
| Gross operating margin | 9900 | €61,775 | €100,642 | +€38,867 | +62.9% |
| Operating profit (loss) | 9901 | €57,818 | €98,420 | +€40,601 | +70.2% |
| Financial income | 75/76B | - | €591 | +€591 | |
| Recurring financial income | 75 | - | €591 | +€591 | |
| Financial charges | 65/66B | €9,503 | €13,745 | +€4,242 | +44.6% |
| Recurring financial charges | 65 | €9,503 | €13,745 | +€4,242 | +44.6% |
| Profit (loss) for the period before taxes | 9903 | €48,315 | €85,266 | +€36,951 | +76.5% |
| Income taxes | 67/77 | €13,328 | €23,379 | +€10,051 | +75.4% |
| Profit (loss) for the period | 9904 | €34,987 | €61,887 | +€26,899 | +76.9% |
| Profit (loss) for the period to be appropriated | 9905 | €34,987 | €61,887 | +€26,899 | +76.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.